125 related articles for article (PubMed ID: 12530010)
1. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
Wesolowska O; Molnár J; Motohashi N; Michalak K
Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
3. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
4. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity.
Hendrich AB; Wesołowska O; Poła A; Motohashi N; Molnár J; Michalak K
Mol Membr Biol; 2003; 20(1):53-60. PubMed ID: 12745926
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
Ferreira MJ; Gyémánt N; Madureira AM; Molnár J
Anticancer Res; 2005; 25(5):3259-62. PubMed ID: 16101136
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
[TBL] [Abstract][Full Text] [Related]
7. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the MDR1 transporter by new phenothiazine derivatives.
Kónya A; Andor A; Sátorhelyi P; Németh K; Kurucz I
Biochem Biophys Res Commun; 2006 Jul; 346(1):45-50. PubMed ID: 16750172
[TBL] [Abstract][Full Text] [Related]
9. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
Wesołowska O; Molnar J; Ocsovszki I; Michalak K
In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
[TBL] [Abstract][Full Text] [Related]
11. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
[TBL] [Abstract][Full Text] [Related]
13. Constituents of Carpobrotus edulis inhibit P-glycoprotein of MDR1-transfected mouse lymphoma cells.
Martins A; Vasas A; Schelz Z; Viveiros M; Molnár J; Hohmann J; Amaral L
Anticancer Res; 2010 Mar; 30(3):829-35. PubMed ID: 20393003
[TBL] [Abstract][Full Text] [Related]
14. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
Ford JM; Prozialeck WC; Hait WN
Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
[TBL] [Abstract][Full Text] [Related]
15. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
[TBL] [Abstract][Full Text] [Related]
17. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
[TBL] [Abstract][Full Text] [Related]
18. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
19. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
20. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
